Please login to the form below

Not currently logged in
Email:
Password:

HAS

This page shows the latest HAS news and features for those working in and with pharma, biotech and healthcare.

New chair for Europe’s key medicines committee

New chair for Europe’s key medicines committee

The European Medicines Agency committee responsible for reviewing all innovative new medicines has a new chair, Germany’s Harald Enzmann. ... He currently serves as BfArM’s Head of European and International Affairs and has been a member of the CHMP,

Latest news

  • Imfinzi aces survival challenge in lung cancer Imfinzi aces survival challenge in lung cancer

    Long-awaited data with AstraZeneca’s checkpoint inhibitor Imfinzi suggest it could become the go-to treatment for mid-stage lung cancer patients whose diseases has not spread widely. ... Imfinzi has just been approved in Europe for this patient group

  • Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3 Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3

    Daiichi-Sankyo has ambitions to carve out a slice of the HER2 inhibitor market, and is pitting its antibody drug conjugate (ADC) against one of the incumbents – Roche’s Kadcyla – in ... The Japanese drugmaker’s has started recruiting patients

  • AstraZeneca chief on Brexit: “it’s going to be really painful” AstraZeneca chief on Brexit: “it’s going to be really painful”

    In a pair of articles in the Times and Sunday Times, AZ’s CEO says the company has increased its medicine stocks by around 20%, and “wasted”some £40m ($53m) building ... footing. Yet despite the turnaround he has faced two shareholder revolts over

  • Roche’s Tecentriq misses survival mark in frontline NSCLC Roche’s Tecentriq misses survival mark in frontline NSCLC

    The company is still hoping that Tecentriq will hit the OS target when final results are reported next year, but for now Merck’s PD-1 inhibitor Keytruda (pembrolizumab) – which has ... trial. Keytruda has been approved as a monotherapy for squamous

  • New Awards scheme for medical and scientific professionals

    Building on the success of the Medical Science Liaison of the Year competition, PharmaTimes Media has unveiled a brand new awards programme, which specifically recognises the achievements of medical and scientific ... Demand for this new initiative has

More from news
Approximately 1 fully matching, plus 1,478 partially matching documents found.

Latest Intelligence

  • Made in China Made in China

    Meanwhile the national medicines regulator the Chinese Food and Drug Administration has also been reformed and renamed as the National Medical Products Administration of China (NMPA). ... In 2018 it has issued a flurry of approvals to new and innovative

  • The critical role of science in healthcare communications The critical role of science in healthcare communications

    Add to this, today’s empowered patient, who has more access to health information, and misinformation, from both valid and questionable Internet sources.

  • Cannes Lions Healthcare Agency of the Year – championing change and demanding more… Cannes Lions Healthcare Agency of the Year – championing change and demanding more…

    But as you’d expect, their ability to use technology has transformed how they operate. ... The clichéd smiling patient has been the easy solution. Today we must build partnerships at an emotional level, with understanding, empathy and creativity.

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    PRIME has come as a result of promising results in a phase I/IIa study which shows the ability of RG6042 to reduce the toxic mutant huntingtin protein (mHTT). ... Still work to do. The EMA has proactively sought feedback from those who have participated

  • The race for an HIV ‘cure’ The race for an HIV ‘cure’

    The fight to control HIV has been a towering triumph for the pharmaceutical industry. ... The progress, in human and medical terms, has been profound and the 22.

More from intelligence
Approximately 0 fully matching, plus 775 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1,042 partially matching documents found.

Latest from PMHub

  • Transforming Mental Health in Ghana

    Attigo, part of the Mednet Group, has been working on the creation of the Community Mental Health Project.

  • Star announce PharmaDoctor partnership

    Already the UK’ s leading provider of pharmacy-based clinical service support packages, PharmaDoctor has recently broadened and strengthened their Medical, Commercial and Digital team capability to accelerate the expansion of

  • The gene therapy revolution

    There has already been one notable disappointment. In 2017 uniQure pulled its gene therapy, Glybera (alipogene tiparvovec) for the rare inherited disorder lipoprotein lipase deficiency (LPLD) from Europe after 5 years, ... https://www.technologyreview.com

  • Bedrock scoops top prizes at Digital Awards

    Awards Chair Rachel Farrow said – “ As we saw in 2017, there has been a wide spread of Gold awards across the agencies showing that there are numerous highly talented agencies producing

  • More tell, less sell: HCP-centric comms

    But what has this got to do with marketing to HCPs?’, you may ask. ... One example has been the shift in the balance of the HCP– patient relationship.

More from PMHub
Approximately 0 fully matching, plus 1,113 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Congress Effectiveness Management
Maximising the ROI of scientific meetings...
Shanghai
Biopharma's Future: Made in China
The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise...
Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...

Infographics